Method for detecting a bacterial pathogen
A method is provided for detecting a bacterial pathogen in a sample. One step of the method includes obtaining a sample and then subjecting the sample to nested PCR. The nested PCR is conducted in the presence of at least two outer oligonucleotide primers complementary to a target nucleotide sequence of the bacterial pathogen so that a first amplified product is produced. The target nucleotide sequence includes at least a portion of a 16S-23S ribosomal RNA sequence. The first amplified product is subjected to the nested PCR in the presence of at least two inner oligonucleotide primers complementary to the nucleotide sequence of the first amplified product so that a second amplified product is obtained. Detection of the second amplified product indicates the presence of the bacterial pathogen in the sample.
1. A method for detecting a bacterial pathogen in amniotic fluid, the method comprising the steps of:
obtaining a sample of the amniotic fluid;
subjecting the sample to nested PCR;
wherein the nested PCR is conducted in the presence of at least two outer oligonucleotide primers complementary to a target nucleotide sequence of the bacterial pathogen so that a first amplified product is produced, the target nucleotide sequence spanning between at least a portion of a 16S and 23S ribosomal RNA sequence;
wherein the first amplified product spanning between at least a portion of a 16S and 23S ribosomal RNA sequence is subject to the nested PCR in the presence of at least two inner oligonucleotide primers complementary to the nucleotide sequence of the first amplified product so that a second amplified product is obtained; and
detecting the second amplified product, wherein the second amplified product indicates the presence of the bacterial pathogen in the sample,
wherein the at least two outer oligonucleotide primers being selected from the group consisting of 5′-GGATTAGATACCCTGGTAGTC-3′ (SEQ ID NO:1) and 5′-GGAGTATTTAGCCTT-3′ (SEQ ID NO:2).
2. The method of claim 1 , the at least two inner oligonucleotide primers being selected from the group consisting of 5′-GGATTAGATACCCTGGTAGTC-3′ (SEQ ID NO1), 5′-GTTTGATCCTGGCTCAG-3′ (SEQ ID NO:3), 5′-GGTACTTAGATGTTTCAGTTC-3′ (SEQ ID NO:4), and 5′-(G/T)TTCGCTCGCC(A/G)CTAC-3′ (SEQ ID NO:5).
3. The method of claim 1 further comprising the step of identifying the bacterial pathogen corresponding to the second amplified product.
4. The method of claim 3 , the step of identifying the bacterial pathogen including cloning the second amplified product into a construct and DNA sequencing conducted in the presence of at least two detection oligonucleotide primers selected from the group consisting of 5′-GTAAAACGACGGCCAGT-3′ (SEQ ID NO:6) and 5′-CAGGAAACAGCTATGAC-3′ (SEQ ID NO:7).
5. A method for detecting a bacterial pathogen in amniotic fluid, the method comprising the steps of:
obtaining a sample of the amniotic fluid;
subjecting the sample to nested PCR;
wherein the nested PCR is conducted in the presence of at least two outer oligonucleotide primers complementary to a target nucleotide sequence of the bacterial pathogen so that a first amplified product is produced, the target sequence comprising at least a portion of a 16S ribosomal RNA sequence, an intergene region, and at least a portion of a 23S ribosomal RNA sequence, the at least two outer oligonucleotide primers being selected from the group consisting of 5′-GGATTAGATACCCTGGTAGTC-3′ (SEQ ID NO:1) and 5′-GGAGTATTTAGCCTT-3′ (SEQ ID NO:2);
wherein the first amplified product is subject to the nested PCR in the presence of at least two inner oligonucleotide primers complementary to the nucleotide sequence of the first amplified product so that a second amplified product is obtained, the first amplified product comprises at least a portion of a 16S ribosomal RNA sequence, an intergene region, and at least a portion of a 23S ribosomal RNA sequence, the at least two inner oligonucleotide primers being selected from the group consisting of 5′-GGATTAGATACCCTGGTAGTC-3′ (SEQ ID NO:1), 5′-GTTTGATCCTGGCTCAG-3′ (SEQ ID NO:3), 5′-GGTACTTAGATGTTTCAGTTC-3′ (SEQ ID NO:4), and 5′-(G/T)TTCGCTCGCC(A/G)CTAC-3′ (SEQ ID NO:5), and
detecting the second amplified product, wherein the second amplified product indicates the presence of the bacterial pathogen in the sample.
6. The method of claim 5 further comprising the step of identifying the bacterial pathogen corresponding to the second amplified product.
7. The method of claim 6 , the step of identifying the bacterial pathogen including cloning the second amplified product into a construct and DNA sequencing conducted in the presence of at least two detection oligonucleotide primers selected from the group consisting of 5′-GTAAAACGACGGCCAGT-3′ (SEQ ID NO:6) and 5′-CAGGAAACAGCTATGAC-3′ (SEQ ID NO:7).